$MAIA Biotechnology (MAIA.US)$ (RTTNews) - MAIA Biotechnology, Inc. (MAIA) announced the FDA has cleared Investigational New Drug application for THIO to be evaluated in the U.S. as part of THIO-101, the company's ongoing global phase 2 clinical study in patients with advanced Non-Small Cell Lung Cancer. THIO is being tested in sequential combination with Regeneron's anti PD-1 monoclonal antibody cemiplimab to evaluate anti-tumor activity and immune response in...
$Novo Integrated Sciences (NVOS.US)$ Novo 綜合科學獲得了 10 億美元的主要抵押品轉讓交易,該交易將在未來 15 年內滿足其資本要求。行政長官 Robert Mattacchione 表示,該協議將使該醫療保健公司能夠追求其國際增長目標。股份超過兩倍,達到 43 美分。
已翻譯
$Tharimmune (THAR.US)$ how long will the stand off last between bid and ask?already. Thank you for your support.
$FaZe Holdings (FAZE.US)$ where do you guys expect this stock to go today?
2
2
$T2 Biosystems (TTOO.US)$ it's been cleared for sale..not sure why given substantially equivalent status...
1
$T2 Biosystems (TTOO.US)$ the fda news is not good for the stock. substantially equivalent means that it is not unique and is basically the same as an already patented drug.
2
5